Healthcare Unicorn Pharmeasy Acquires Majority Stake In Thyrocare Technologies: Report
PharmEasy (Source: Entrackr)
API Holdings Ltd (API), the parent company of digital healthcare brand Pharmeasy, is set to acquire automated accredited diagnostic laboratory Thyrocare Technologies, making the first such deal of a listed entity by an Indian unicorn.
API Holdings has signed definitive documents to acquire 66.1 per cent stake in Thyrocare Technologies Ltd (Thyrocare) from Dr A. Velumani and affiliates at a price of Rs 1,300 per share aggregating to Rs 4,546 crore.
The transaction is subject to regulatory and other applicable customary approvals.
Docon Technologies Pvt Ltd, a 100 per cent subsidiary of API, will be the acquirer and shall make an open offer for an additional 26 per cent stake.
PharmEasy to acquire 66 1% stake in Thyrocare for Rs 4546 crores from Dr A Velumani and affiliates
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Pharmeasy buys 66 1 percent of Thyrocare, the first listed company acquired by an Indian unicorn
ibtimes.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.co.in Daily Mail and Mail on Sunday newspapers.
First acquisition of listed firm by Indian unicorn: Pharmeasy picks up 66 1% in Thyrocare
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.